Propane, 1-butoxy-2,3-epoxy-
RTECS #
TX4200000
CAS #
Updated
December 2017
Molecular Weight
130.21
Molecular Formula
C7H14O2
Synonyms
2,3-Epoxypropyl butyl ether
Ageflex BGE
BGE (OSHA)
Butyl glycidyl ether
Ether, butyl 2,3-epoxypropyl
Ether, butyl glycidyl
Glycidyl butyl ether
n-Butyl glycidyl ether
n-Butyl glycidyl ether (ACGIH:OSHA)
Oxirane, (butoxymethyl)- (9CI)
TK 10408
Ageflex BGE
BGE (OSHA)
Butyl glycidyl ether
Ether, butyl 2,3-epoxypropyl
Ether, butyl glycidyl
Glycidyl butyl ether
n-Butyl glycidyl ether
n-Butyl glycidyl ether (ACGIH:OSHA)
Oxirane, (butoxymethyl)- (9CI)
TK 10408
Skin and Eye Irritation and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
eye /rabbit | 91 mg | mild | AMIHAB 14,250,1956 |
eye /rabbit | 750 µg/24H | severe | 85JCAE -,774,1986 |
skin /rabbit | 454 mg/3D | mild | AMIHAB 14,250,1956 |
skin /rabbit | 20 mg/24H | moderate | 85JCAE -,774,1986 |
Mutation Data and Reference
System Test | Route/Organism/Tissue | Dose | Reference |
---|---|---|---|
DNA Damage | /Escherichia coli | 1 µmol/L | ARTODN 46,277,1980 |
micronucleus test | intraperitoneal/mouse | 675 mg/kg | ENMUDM 2,521,1980 |
mutation in microorganisms | /Salmonella typhimurium | 10 mg/plate (+/-enzymatic activation step) | MUREAV 66,367,1979 |
mutation in microorganisms | /Escherichia coli | 20 µmol/L (-enzymatic activation step) | ARTODN 46,277,1980 |
other mutation test systems | /Escherichia coli | 1 mmol/L | MUREAV 231,205,1990 |
sister chromatid exchange | lung/hamster | 2500 µmol/L | MUREAV 249,55,1991 |
Reproductive Effects Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
skin/mouse | 36 gm/kg (24D male) | Reproductive: Effects on embryo or fetus: Fetal death | MUREAV 124,225,1983 |
Acute Toxicity Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
In Vitro/Human, leukemia cells | Inhibitor Concentration (5 percent kill): 5500 mg/L/30M | In Vitro Toxicity Studies: Cell counting | TIVIEQ 27,857,2013 |
In Vitro/Human, leukemia cells | Inhibitor Concentration Low: 776 mg/L/30M | In Vitro Toxicity Studies: Other assays | TIVIEQ 27,857,2013 |
In Vitro/Human, leukemia cells | Inhibitor Concentration (25 percent kill): 185.3 mg/L/24H | In Vitro Toxicity Studies: Cell viability (dye exclusion): trypan blue assay etc. | TIVIEQ 26,1150,2012 |
In Vitro/Human, lymphocyte | Inhibitor Concentration (30 percent kill): >200 mg/L/45H | In Vitro Toxicity Studies: Cell viability (dye exclusion): trypan blue assay etc. | TIVIEQ 29,901,2015 |
In Vitro/Human, lymphocyte | Inhibitor Concentration (50 percent kill): 149 mg/L/45H | In Vitro Toxicity Studies: Other assays | TIVIEQ 29,901,2015 |
In Vitro/Human, monocyte | Inhibitor Concentration Low: 2500 mg/L/2H | In Vitro Toxicity Studies: Other assays | TIVIEQ 27,1233,2013 |
In Vitro/Human, skin | Inhibitor Concentration (50 percent kill): 620.9 µmol/L/48H | In Vitro Toxicity Studies: Cell viability (mitochondrial reductase assays): MTT, XTT, MTS, WSTs assays etc. | TIVIEQ 29,688,2015 |
In Vitro/Human, skin | Inhibitor Concentration (50 percent kill): 580.7 µmol/L/48H | In Vitro Toxicity Studies: Cell metabolic activity: Alamar Blue assay etc. | TIVIEQ 29,688,2015 |
In Vitro/Human, skin | Inhibitor Concentration (30 percent kill): 475.2 µmol/L/48H | In Vitro Toxicity Studies: Cell viability (mitochondrial reductase assays): MTT, XTT, MTS, WSTs assays etc. | TIVIEQ 29,688,2015 |
In Vitro/Human, skin | Inhibitor Concentration (30 percent kill): 439.5 µmol/L/48H | In Vitro Toxicity Studies: Cell metabolic activity: Alamar Blue assay etc. | TIVIEQ 29,688,2015 |
In Vitro/Human, skin | Inhibitor Concentration Low: 50 pph/15M | In Vitro Toxicity Studies: Other assays | TIVIEQ 29,787,2015 |
In Vitro/Human, skin | Inhibitor Concentration (50 percent kill): 218.5 µmol/L/48H | In Vitro Toxicity Studies: Other assays | TXAPA9 245,281,2010 |
In Vitro/jrd | Inhibitor Concentration (50 percent kill): 4.22 mg/L/24H | In Vitro Toxicity Studies: Other assays | TIVIEQ 28,626,2014 |
inhalation/mouse | lethal concentration (50 percent kill): 260 mg/m3 | Behavioral: Somnolence (general depressed activity) Lung, Thorax, or Respiration: Dyspnea Lung, Thorax, or Respiration: Respiratory depression | GISAAA 51(8),91,1986 |
inhalation/rat | lethal concentration (50 percent kill): 1030 ppm/8H | Eye: Lacrimation Gastrointestinal: Changes in structure or function of salivary glands Lung, Thorax, or Respiration: Dyspnea | AMIHAB 14,250,1956 |
intraperitoneal/mouse | lethal dose (50 percent kill): 700 mg/kg | Brain and Coverings: Recordings from specific areas of CNS Behavioral: Somnolence (general depressed activity) Behavioral: Ataxia | AMIHAB 14,250,1956 |
intraperitoneal/rat | lethal dose (50 percent kill): 1140 mg/kg | Brain and Coverings: Recordings from specific areas of CNS Behavioral: Somnolence (general depressed activity) Behavioral: Ataxia | AMIHAB 14,250,1956 |
oral/mouse | lethal dose (50 percent kill): 1530 mg/kg | Brain and Coverings: Recordings from specific areas of CNS Behavioral: Somnolence (general depressed activity) Behavioral: Ataxia | AMIHAB 14,250,1956 |
oral/rat | lethal dose (50 percent kill): 1660 mg/kg | Behavioral: Somnolence (general depressed activity) Lung, Thorax, or Respiration: Dyspnea Lung, Thorax, or Respiration: Respiratory depression | GISAAA 51(8),91,1986 |
skin/rabbit | lethal dose (50 percent kill): 2520 µL/kg | AIHAAP 23,95,1962 | |
skin/rat | lethal dose (50 percent kill): >2150 mg/kg | TSCAT* OTS0515483 |
Reviews
Organization | Standard | Reference |
---|---|---|
American Conference of Governmental Industrial Hygienists (ACGIH) | Threshold Limit Value-time-weighted average 3 ppm (skin, sen) | DTLVS* TLV/BEI,2013 |
TOXICOLOGY REVIEW | MUREAV 721,27,2011 |
Standards and Regulations
Organization | Standard | Reference |
---|---|---|
Mine Safety and Health Administration (MSHA) STANDARD-air | time-weighted average 50 ppm (270 mg/m3) | DTLVS* 3,33,1971 |
Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN check ACGIH TLV; | ||
Occupational Exposure Limit IN SINGAPORE, VIETNAM check ACGIH TLV | ||
Occupational Exposure Limit-AUSTRALIA | time-weighted average 25 ppm (133 mg/m3), JUL2008 | |
Occupational Exposure Limit-BELGIUM | time-weighted average 3 ppm (16.2 mg/m3), Skin, MAR2002 | |
Occupational Exposure Limit-DENMARK | time-weighted average 6 ppm (30 mg/m3), carc, MAY2011 | |
Occupational Exposure Limit-FINLAND | short term exposure limit 25 ppm (140 mg/m3), NOV2011 | |
Occupational Exposure Limit-FRANCE | VME 25 ppm (135 mg/m3), C3 Carcinogen, FEB2006 | |
Occupational Exposure Limit-ICELAND | time-weighted average 6 ppm (30 mg/m3), sen, NOV2011 | |
Occupational Exposure Limit-KOREA | time-weighted average 25 ppm (135 mg/m3), 2006 | |
Occupational Exposure Limit-MEXICO | time-weighted average 25 ppm (135 mg/m3), 2004 | |
Occupational Exposure Limit-NEW ZEALAND | time-weighted average 25 ppm (133 mg/m3), sen, JAN2002 | |
Occupational Exposure Limit-PERU | time-weighted average 25 ppm (133 mg/m3), JUL2005 | |
Occupational Exposure Limit-SWEDEN | time-weighted average 10 ppm (50 mg/m3);short term exposure limit 15 ppm (80 mg/m3), Sen, JUN2005 | |
Occupational Exposure Limit-SWITZERLAND | MAK-week 25 ppm (135 mg/m3), KZG-week 50 ppm (270 mg/m3), skin, sen, JAN2011 | |
Occupational Exposure Limit-THE NETHERLANDS | MAC-TGG 135 mg/m3, 2003 | |
Occupational Exposure Limit-THE PHILIPPINES | time-weighted average 50 ppm (270 mg/m3), JAN1993 | |
Occupational Exposure Limit-TURKEY | time-weighted average 50 ppm (270 mg/m3), JAN1993 | |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Construction) | 8H time-weighted average 50 ppm (270 mg/m3) | CFRGBR 29,1926.55,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Federal Contractors) | 8H time-weighted average 50 ppm (270 mg/m3) | CFRGBR 41,50-204.50,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (General Industry) | 8H time-weighted average 50 ppm (270 mg/m3) | CFRGBR 29,1910.1000,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Shipyards) | 8H time-weighted average 50 ppm (270 mg/m3) | CFRGBR 29,1915.1000,1993 |
NIOSH Documentation and Surveillance
Organization | Standard | Reference |
---|---|---|
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO BUTYL GLYCIDYL ETHER-air | ceiling concentration 5.6 ppm/15M | NIOSH* DHHS #92-100,1992 |
National Occupational Exposure Survey 1983 | Hazard Code 14720; Number of Industries 56; Total Number of Facilities 2593; Number of Occupations 57; Total Number of Employees Exposed 60217; Total Number of Female Employees Exposed 14929 | |
National Occupational Hazard Survey 1974 | Hazard Code 14720; Number of Industries 37; Total Number of Facilities 1596; Number of Occupations 45; Total Number of Employees Exposed 19839 |
Status in Federal Agencies
Organization | Reference |
---|---|
EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE | FEREAC 47,26992,82 |
EPA TSCA Section 8(b) CHEMICAL INVENTORY | |
EPA TSCA Section 8(d) unpublished health/safety studies | |
EPA TSCA Section 8(e) Risk Notification, 8EHQ-0293-8718;8EHQ-0892-9000 | |
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001 | |
NIOSH Analytical Method, 1994: n-Butyl glycidyl ether, 1616 | |
NIOSH CURRENT INTELLIGENCE BULLETIN 29, 1978 |
Page last reviewed: November 16, 2018
Content
source: National Institute for Occupational Safety and Health